← Back to Influence Map
Inflation Reduction Act - Drug Pricing Provisions (H.R.5376)
enactedFirst-ever Medicare drug price negotiation authority. Starting in 2026, Medicare can negotiate prices for 10 high-cost drugs, expanding to 20 by 2029. Also caps insulin at $35/month for Medicare beneficiaries and requires manufacturers to pay rebates if prices rise faster than inflation.
Who took a position
Lobbied on (103)
- CENTERPOINT ENERGY, INC.
- CAPTURA CORP.
- GEOSYNTHETIC MATERIALS ASSOCIATION - ATA (FORMERLY KNOWN AS GMA - IFAI)
- COLONIAL PIPELINE COMPANY
- AVANGRID INC
- ALEXION PHARMACEUTICALS, INC.
- HORIZON THERAPEUTICS
- AMOUNT
- OMEROS CORPORATION
- CSL BEHRING
- UNITED MINE WORKERS OF AMERICA
- PACIFIC GAS AND ELECTRIC COMPANY
- and 91 more
Supporting (1)
Opposing (0)
- No opposing positions recorded.